{"id":558430,"date":"2026-06-12T02:00:00","date_gmt":"2026-06-12T00:00:00","guid":{"rendered":"https:\/\/medizinonline.com\/approches-therapeutiques-davenir-pour-la-cbp-la-csp-et-lhai-quelles-sont-les-dernieres-avancees\/"},"modified":"2026-06-17T11:00:07","modified_gmt":"2026-06-17T09:00:07","slug":"approches-therapeutiques-davenir-pour-la-cbp-la-csp-et-lhai-quelles-sont-les-dernieres-avancees","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/fr\/approches-therapeutiques-davenir-pour-la-cbp-la-csp-et-lhai-quelles-sont-les-dernieres-avancees\/","title":{"rendered":"Approches th\u00e9rapeutiques d&#8217;avenir pour la CBP, la CSP et l&#8217;HAI : quelles sont les derni\u00e8res avanc\u00e9es ?"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Les agonistes des PPAR utilis\u00e9s en traitement de deuxi\u00e8me intention se sont r\u00e9v\u00e9l\u00e9s efficaces dans la cholangite biliaire primitive (CBP), non seulement dans le cadre d\u2019essais cliniques, mais \u00e9galement en conditions r\u00e9elles, comme le montrent les r\u00e9sultats de recherches r\u00e9centes. Dans le cas de la cholangite scl\u00e9rosante primitive (CSP), l\u2019acide norucholique (NCA) a permis d\u2019am\u00e9liorer les param\u00e8tres biologiques pertinents et a d\u00e9montr\u00e9 des effets h\u00e9patoprotecteurs. En ce qui concerne l\u2019h\u00e9patite auto-immune (AIH), une analyse r\u00e9cente a \u00e9valu\u00e9 les performances du mycoph\u00e9nolate mof\u00e9til par rapport \u00e0 l\u2019azathioprine, chacun \u00e9tant associ\u00e9 \u00e0 la prednisolone.  <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/fr\/mon-compte\/paquets\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/fr\/se-connecter\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Ffr%2Fapproches-therapeutiques-davenir-pour-la-cbp-la-csp-et-lhai-quelles-sont-les-dernieres-avancees%2F\">Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Les agonistes des PPAR utilis\u00e9s en traitement de deuxi\u00e8me intention se sont r\u00e9v\u00e9l\u00e9s efficaces dans la cholangite biliaire primitive (CBP), non seulement dans le cadre d\u2019essais cliniques, mais \u00e9galement en&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/fr\/mon-compte\/paquets\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/fr\/se-connecter\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Ffr%2Fapproches-therapeutiques-davenir-pour-la-cbp-la-csp-et-lhai-quelles-sont-les-dernieres-avancees%2F\">Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":558381,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Maladies h\u00e9patiques auto-immunes  ","footnotes":"[{\"content\":\"<em>Crit\\u00e8res de r\\u00e9ponse POISE = ALP [phosphatase alcaline] <1,67 fois la LSN, ainsi qu'une r\\u00e9duction de 15 % de l'ALP et une bilirubine totale dans les limites de la normale apr\\u00e8s 1 an.  <\\\/em>\",\"id\":\"4b3154c2-2e71-44d9-b2fc-5c3e68c86fac\"},{\"content\":\"<em>ULN (upper limit of normal) = limite sup\\u00e9rieure de la fourchette normale<\\\/em>\",\"id\":\"85539fe2-6d0e-4c82-9a2e-85cb9bf78fe2\"}]"},"category":[11549,11527,11414,11315,11535],"tags":[94706,94705,72855,14304,32535,32537,63827,72858,94708,94707,32536,27676,32539,82735],"powerkit_post_featured":[],"class_list":["post-558430","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-fr","category-etudes","category-gastro-enterologie-et-hepatologie","category-medecine-interne-generale","category-rapports-de-congres","tag-acide-norucholique","tag-agonistes-des-ppar","tag-aih-fr","tag-azathioprine-fr","tag-cholangite-biliaire-primaire","tag-cholangite-sclerosante-primaire","tag-hepatite-auto-immune","tag-maladies-auto-immunes-du-foie","tag-mycophenolate-mofetil-2","tag-nca","tag-pbc-fr","tag-prednisolone-fr","tag-psc-fr","tag-traitement-de-deuxieme-intention","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-06-27 04:34:04","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"fr_FR","wpml_translations":{"it_IT":{"locale":"it_IT","id":558716,"slug":"approcci-terapeutici-allavanguardia-per-la-pbc-la-psc-e-laih-quali-sono-le-novita","post_title":"Approcci terapeutici all\u2019avanguardia per la PBC, la PSC e l\u2019AIH: quali sono le novit\u00e0?","href":"https:\/\/medizinonline.com\/it\/approcci-terapeutici-allavanguardia-per-la-pbc-la-psc-e-laih-quali-sono-le-novita\/"},"pt_PT":{"locale":"pt_PT","id":558740,"slug":"abordagens-terapeuticas-inovadoras-para-a-pbc-a-psc-e-a-aih-quais-sao-as-novidades","post_title":"Abordagens terap\u00eauticas inovadoras para a PBC, a PSC e a AIH: Quais s\u00e3o as novidades?","href":"https:\/\/medizinonline.com\/pt-pt\/abordagens-terapeuticas-inovadoras-para-a-pbc-a-psc-e-a-aih-quais-sao-as-novidades\/"},"es_ES":{"locale":"es_ES","id":558746,"slug":"enfoques-terapeuticos-innovadores-para-la-cbp-la-csp-y-la-hai-que-novedades-hay","post_title":"Enfoques terap\u00e9uticos innovadores para la CBP, la CSP y la HAI: \u00bfqu\u00e9 novedades hay?","href":"https:\/\/medizinonline.com\/es\/enfoques-terapeuticos-innovadores-para-la-cbp-la-csp-y-la-hai-que-novedades-hay\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/558430","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/comments?post=558430"}],"version-history":[{"count":2,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/558430\/revisions"}],"predecessor-version":[{"id":558715,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/558430\/revisions\/558715"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media\/558381"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media?parent=558430"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/category?post=558430"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/tags?post=558430"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/powerkit_post_featured?post=558430"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}